Demitra Manjoros, MD, Bryn Mawr Hospital breast surgery fellow, recently received the George Peters Award from the American Society of Breast Surgeons (ASBS) for the best abstract presented by a breast fellow at the ASBS 14th Annual Meeting that took place in Chicago in May.
“We are so proud of the accomplishments that Dr. Manjoros made at the ASBS Annual Meeting,” says Brenda DeFeo, vice president of Administration at Bryn Mawr Hospital. “The presentation demonstrated the tremendous knowledge and expertise she possesses in the field of breast surgery, and really gives insight into the skill she provides to the patients of Bryn Mawr Hospital.”
Along with Manjoros, Andrea V. Barrio, MD, attending breast surgeon, Bryn Mawr Hospital, was the senior author of the paper and is also the director of research for the breast surgery fellows. The manuscript was also co-authored by Thomas G. Frazier, MD, director of the Bryn Mawr Hospital Breast Fellowship Program; Jose-Jaime Alberty-Oller, MD, Bryn Mawr Hospital breast surgery fellow; and Bryn Mawr Hospital research assistant, Abigail Collett.
The paper, The Value of Six Month Interval Imaging following Benign Radiologic-Pathologic Concordant Minimally Invasive Breast Biopsy, concluded that routine imaging studies conducted less than a year after a benign breast biopsy are an unnecessary drain on healthcare dollars. Through their research, the authors found that half of the patients with benign lesions received at least one imaging exam during this time period, and only one patient (0.6 percent) was diagnosed with a cancer.
“In today’s cost-conscious healthcare environment, the key word in our conclusion is routine. In some cases, physicians will have clear reasons to feel such an exam is appropriate,” said Dr. Manjoros. “But in this study, the yields for finding a malignancy with interval imaging were extremely low, and testing cannot be justified across this entire patient population.”
The George Peters Award was established by the ASBS to honor Dr. George N. Peters, who was instrumental in bringing together the Susan G. Komen Breast Cancer Foundation, The American Society of Breast Surgeons, the American Society of Breast Disease, and the Society of Surgical Oncology to develop educational objectives for breast fellowships. The educational objectives were first used to award Komen Interdisciplinary Breast Fellowships. Subsequently, the curriculum was used for the breast fellowship credentialing process that has led to the development of a nationwide matching program for breast fellowships.
Founded in 1985, Main Line Health is a not-for-profit health system serving portions of Philadelphia and its western suburbs. Main Line Health’s commitment—to deliver advanced medicine to treat and cure disease while also playing an important role in prevention and disease management as well as training physicians and other health care providers—reflects our intent to keep our community and ourselves well ahead. A team of more than 10,000 employees and 2,000 physicians care for patients throughout the Main Line Health system.
At Main Line Health’s core are four of the region’s most respected acute care hospitals—Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital and Riddle Hospital—as well as one of the nation’s recognized facilities for rehabilitative medicine, Bryn Mawr Rehabilitation Hospital.
The Main Line Health system also includes Mirmont Treatment Center for drug and alcohol recovery; Main Line Health HomeCare & Hospice, which includes skilled home health care, hospice and home infusion services; Main Line Health Centers, primary and specialty care, lab and radiology, and other outpatient services located in Broomall, Collegeville, Concordville, Exton and Newtown Square; Lankenau Institute for Medical Research, a biomedical research organization; and Main Line HealthCare, one of the region’s largest multispecialty physician networks.
Main Line Health is the recipient of numerous awards for quality care and service, including System Magnet® designation, the nation’s highest distinction for nursing excellence, the Mid-Atlantic Alliance for Performance Excellence (MAAPE) Excellence Award, and recognition as among the nation’s best employers by Forbes magazine. Main Line Health is committed to creating an environment of diversity, respect and inclusion and has proudly embraced the American Hospital Association’s #123forEquity Pledge to Act to eliminate disparities in care. We are dedicated to advancing patient-centered care, education and research to help our community stay healthy.
Bryn Mawr Hospital, a member of Main Line Health, is a 234-bed, not-for-profit acute-care teaching hospital dedicated to helping the community stay well ahead on the path to lifelong health. Boasting a brand new Patient Pavilion that opened in February 2019, Bryn Mawr Hospital has received both regional and national recognition for its excellence in providing state-of-the-art, quality care. Bryn Mawr Hospital was named among the top 10 hospitals in the Philadelphia region, and the top 20 hospitals in Pennsylvania, in U.S. News & World Report’s Best Hospitals rankings for 2018–19, and Bryn Mawr Hospital has earned Magnet® designation for the third time for its superior nursing staff. The hospital offers a full range of services, including cancer care, orthopedic care, cardiovascular care, behavioral health, maternity care, bariatric surgery, neurovascular and a level III neonatal intensive care unit, all aided by a dedicated team of health care professionals and innovative technologies. Through Bryn Mawr Hospital’s collaboration with the Jefferson Hospital for neuroscience, the university-affiliated Neurovascular Center offers rapid access to advanced diagnostics and treatment options for stroke care. Bryn Mawr Hospital has also collaborated with Nemours/Alfred I. duPont Hospital for Children to include round-the-clock pediatric care for the pediatric unit and in the pediatric emergency department with additional board-certified, fellowship trained pediatric emergency medicine physicians.